Supporting Organizations
Platinum
Sanofi Genzyme - Regeneron

The Sanofi Genzyme and Regeneron collaboration is committed to translating cutting-edge science into groundbreaking medicines for patients with serious needs. Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. Since 2007, Regeneron and Sanofi have collaborated to discover, develop, manufacture and commercialize fully human monoclonal antibodies.